| 摘要 |
The present invention relates to an implant comprising (a) a polymer of the general formula (I) as a matrix material of the implant, wherein n is from 2 to ∞, and R<SUP>1 </SUP>to R<SUP>6 </SUP>are the same or different and represent a halogenalkoxy, alkoxy, alkylsulfonyl, dialkylamino or aryloxy group or a heterocycloalkyl or heteroaryl group having nitrogen as a heteroatom, and at least one halogen substituent; and (b) at least one pharmacologically active agent incorporated into the matrix material, a process for producing the same and the use of a mixture of a polymer having the formula (I) and a pharmacologically active agent for the preparation of a pharmaceutical composition in the form of an implant for the treatment of disorders caused by implantation of said implant in a patient.
|
